Lippert E - Search Results

1

Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.

Tondeur S, Paul F, Riou J, Mansier O, Ranta D, Le Clech L, Lippert E, Tavitian S, Chaoui D, Mercier M, De Renzis B, Cottin L, Cassinat B, Chrétien JM, Ianotto JC, Allangba O, Marzac C, Voillat L, Boyer F, Orvain C, Hunault-Berger M, Girodon F, Kiladjian JJ, Ugo V, Luque Paz D. Tondeur S, et al. Among authors: lippert e. Leukemia. 2021 Mar;35(3):871-875. doi: 10.1038/s41375-020-0991-x. Epub 2020 Jul 21. Leukemia. 2021. PMID: 32694617 No abstract available.

2

Serum erythropoietin measured by chemiluminescent immunometric assay: an accurate diagnostic test for absolute erythrocytosis.

Mossuz P, Girodon F, Hermouet S, Dobo I, Lippert E, Donnard M, Latger-Cannard V, Boiret N, Praloran V, Lecron JC. Mossuz P, et al. Among authors: lippert e. Clin Chem. 2005 Jun;51(6):1018-21. doi: 10.1373/clinchem.2004.047365. Clin Chem. 2005. PMID: 15914784 No abstract available.

3

The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera.

Lippert E, Boissinot M, Kralovics R, Girodon F, Dobo I, Praloran V, Boiret-Dupré N, Skoda RC, Hermouet S. Lippert E, et al. Blood. 2006 Sep 15;108(6):1865-7. doi: 10.1182/blood-2006-01-013540. Epub 2006 May 25. Blood. 2006. PMID: 16728702 Free article.

4

Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis.

Boissinot M, Lippert E, Girodon F, Dobo I, Fouassier M, Masliah C, Praloran V, Hermouet S. Boissinot M, et al. Among authors: lippert e. Blood. 2006 Nov 1;108(9):3223-4. doi: 10.1182/blood-2006-05-021527. Blood. 2006. PMID: 17057021 Free article. No abstract available.

5

JAK2V617F detection and dosage of serum erythropoietin: first steps of the diagnostic work-up for patients consulting for elevated hematocrit.

Girodon F, Lippert E, Mossuz P, Dobo I, Boiret-Dupré N, Lesesve JF, Hermouet S, Praloran V. Girodon F, et al. Among authors: lippert e. Haematologica. 2007 Mar;92(3):431-2. doi: 10.3324/haematol.10660. Haematologica. 2007. PMID: 17339201 Free article.

6

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

Theocharides A, Boissinot M, Girodon F, Garand R, Teo SS, Lippert E, Talmant P, Tichelli A, Hermouet S, Skoda RC. Theocharides A, et al. Among authors: lippert e. Blood. 2007 Jul 1;110(1):375-9. doi: 10.1182/blood-2006-12-062125. Epub 2007 Mar 15. Blood. 2007. PMID: 17363731 Free article.

7

Proteomic study of the impact of the JAK2-V617F mutation on the phenotype of essential thrombocythemia.

Mossuz P, Arlotto M, Hermouet S, Bouamrani A, Lippert E, Girodon F, Dobo I, Vincent P, Cahn JY, Berger F. Mossuz P, et al. Among authors: lippert e. Exp Hematol. 2008 Dec;36(12):1642-7. doi: 10.1016/j.exphem.2008.07.013. Epub 2008 Oct 5. Exp Hematol. 2008. PMID: 18838204 Free article.

8

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.

Lippert E, Girodon F, Hammond E, Jelinek J, Reading NS, Fehse B, Hanlon K, Hermans M, Richard C, Swierczek S, Ugo V, Carillo S, Harrivel V, Marzac C, Pietra D, Sobas M, Mounier M, Migeon M, Ellard S, Kröger N, Herrmann R, Prchal JT, Skoda RC, Hermouet S. Lippert E, et al. Haematologica. 2009 Jan;94(1):38-45. doi: 10.3324/haematol.13486. Epub 2008 Nov 10. Haematologica. 2009. PMID: 19001280 Free PMC article.

9

The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera.

Olcaydu D, Skoda RC, Looser R, Li S, Cazzola M, Pietra D, Passamonti F, Lippert E, Carillo S, Girodon F, Vannucchi A, Reading NS, Prchal JT, Ay C, Pabinger I, Gisslinger H, Kralovics R. Olcaydu D, et al. Among authors: lippert e. Leukemia. 2009 Oct;23(10):1924-6. doi: 10.1038/leu.2009.110. Epub 2009 May 14. Leukemia. 2009. PMID: 19440215 No abstract available.

10

Apolipoprotein A1: A new serum marker correlated to JAK2 V617F proportion at diagnosis in patients with polycythemia vera.

Mossuz P, Bouamrani A, Brugière S, Arlotto M, Hermouet S, Lippert E, Laporte F, Girodon F, Dobo I, Vincent P, Garin J, Cahn JY, Berger F. Mossuz P, et al. Among authors: lippert e. Proteomics Clin Appl. 2007 Dec;1(12):1605-12. doi: 10.1002/prca.200601051. Proteomics Clin Appl. 2007. PMID: 21136658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters